📰 Tender Offer Statement News
Page 3 - Tender Offer Statement News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Tender Offer Statement. Real-time updates on events, politics, business and more.
February 6, 2024
Tafasitamab sold to IncyteNovartis to launch a voluntary public takeover offer for all MorphoSys shares at a price of € 68.00 per share in cashShareholders benefit from attractive premium of 94 percent to the one-month volume weighted average price before January 25, 2024Novartis provides ample resources to maximize...
February 6, 2024
Germany - MorphoSys AG today announced the company entered into a Business Combination Agreement with Novartis data42 AG and Novartis AG based on Novartis intention to submit a voluntary public...
February 2, 2024
Renesas Electronics Corporation and Sequans Communications S.A. today announced that Renesas has extended the expiration date of its tender offer to acquire all of the outstanding ordinary shares...
January 30, 2024
As previously announced on December 22, 2023, Concentra Biosciences, LLC and its wholly owned subsidiary, Concentra Merger Sub II, Inc. , entered into a merger agreement with Theseus...
January 22, 2024
Shareholders to Receive U.S. $0.7575 per Ordinary Share and U.S. $3.03 per ADS in cash Tokyo, Japan and Paris, France--(Newsfile Corp. - January 22, 2024) - Renesas Electronics Corporation (TSE: 6723) ("Renesas") and Sequans Communications S.A. (NYSE: SQNS) ("Sequans") today announced that Renesas has extended the expiration date of its tender offer to acquire all of the outstanding ordinary shares of Sequans for $0.7575 per ordinary share and American Depositary Shares (...
January 19, 2024
LIMASSOL, Cyprus, Jan. 19, 2024 -- GDEV Inc. , an international gaming and entertainment company , today announced the final results of the previously announced tender offer by the Company to...
January 18, 2024
MakeMyTrip Limited , a leading travel service provider in India, today announced that it had issued a Repurchase Right Notice addressed to holders of its 0.00% Convertible Senior Notes due 2028 ....
January 18, 2024
Board of Directors Unanimously Recommends Sinovac Shareholders NOT Tender Shares for purchase pursuant to the Offer to Purchase ...
January 18, 2024
Sinovac Biotech Ltd. NASDAQ SVA SINOVAC or the Company a leading provider of biopharmaceutical products in China announced today that its Board of Directors the Board of Directors unanimously determined that the partial tender offer the Tender Offer by Alternative Liquidity Index LP Alternative Liquidity to acquire up to 10000000 common shares of Sinovac the Shares for 0.03 per share in cash the Offer Price is NOT advisable.
January 5, 2024
Renesas Electronics Corporation and Sequans Communications S.A. today announced that Renesas has extended the expiration date of its tender offer to acquire all of the outstanding ordinary shares...